10x Genomics, Inc. — Director's Dealing 2021

Mar 26, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: 10x Genomics, Inc. (TXG)
CIK: 0001770787
Period of Report: 2021-03-23

Reporting Person: Kosaraju Sridhar (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-01-25	Class A Common Stock	G	7167	$0.00	Disposed	2833	Direct
2021-01-25	Class A Common Stock	G	7167	$0.00	Acquired	18000	Indirect
2021-03-23	Class A Common Stock	S	1200	$173.9625	Disposed	16800	Indirect
2021-03-23	Class A Common Stock	S	100	$175.71	Disposed	16700	Indirect
2021-03-23	Class A Common Stock	S	200	$178.065	Disposed	16500	Indirect

Footnotes

F1: These shares are held by the Kosaraju Family Trust dated June 21, 2014, of which the Reporting Person is trustee (the "Kosaraju Family Trust").

F2: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Kosaraju Family Trust.

F3: This transaction was executed in multiple trades at prices ranging from $173.48 to $174.47. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

F4: This transaction was executed in multiple trades at prices ranging from $177.76 to $178.37. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.